Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee holds informational hearing on bill to pause gene-therapy products after wide-ranging testimony
Summary
Senate Health and Welfare convened an informational hearing on Senate Bill 10‑36, the "Doug Cameron Act," which would impose a moratorium on the administration of any gene‑therapy product for infectious‑disease indications.
Senate Health and Welfare convened an informational hearing on Senate Bill 10‑36, the "Doug Cameron Act," which would impose a moratorium on the administration of any gene‑therapy product for infectious‑disease indications. Sponsor Senator Brandon Shippey opened the hearing, and the committee heard more than two dozen in‑person and remote witnesses both for and against the proposal.
The bill’s sponsor, Senator Brandon Shippey, said the measure was brought to him by a constituent and framed it as a safety pause. Doug Cameron, the constituent whose name is on the bill, told the committee he was injured after receiving a Johnson & Johnson COVID‑19 vaccine in April 2021: "Ten days later, I was paralyzed from a diaphragm down," Cameron said, and he said combined medical bills and out‑of‑pocket expenses have exceeded $2,000,000. His wife, Carla Cameron, described the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
